Introduction to the GLP-1 Vision Loss Lawsuit: GLP-1 Vision Loss Lawsuit: Refers to the massive tidal wave of lawsuits being commenced by individuals taking GLP-1 drugs (Ozempic, Saxenda, Zepbound, Trulicity, Wegovy, etc.) who have suffered severed GLP-1 vision side effects including permanent vision loss and are now filing multiple lawsuits against the manufactures
Recent evidence from in vitro and in vivo studies showed that guggulsterone, a FXR antagonist, lowered plasma TMA/TMAO levels (Gautam et al., 2018)
Yes, GLP-1 receptor agonists can be safely used in people with high blood pressure and may produce modest reductions in systolic blood pressure
Picca A, Calvani R, Coelho-Jnior HJ, Landi F, Bernabei R, Marzetti E (2020) Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration